Lung Cancer
Volume 72, Issue 1 , Pages 23-31 , April 2011

Establishment and phenotypic characterization of the first human pulmonary blastoma cell line

  • Rosa Camerlingo

      Affiliations

    • Department of Experimental Oncology, National Cancer Institute, Via Mariano Semmola, 80131 Naples, Italy
    • These authors contributed equally to this work.
    • ,
  • Renato Franco

      Affiliations

    • Department of Pathology, National Cancer Institute, Naples, Italy
    • These authors contributed equally to this work.
    • ,
  • Virginia Tirino

      Affiliations

    • Department of Experimental Oncology, National Cancer Institute, Via Mariano Semmola, 80131 Naples, Italy
    • ,
  • Monica Cantile

      Affiliations

    • Department of Pathology, National Cancer Institute, Naples, Italy
    • ,
  • Mariano Rocchi

      Affiliations

    • Department of Genetics and Microbiology, University of Bari, Bari, Italy
    • ,
  • Antonello La Rocca

      Affiliations

    • Department of Thoracic Surgery and Oncology, National Cancer Institute, Naples, Italy
    • ,
  • Nicola Martucci

      Affiliations

    • Department of Thoracic Surgery and Oncology, National Cancer Institute, Naples, Italy
    • ,
  • Gerardo Botti

      Affiliations

    • Department of Pathology, National Cancer Institute, Naples, Italy
    • ,
  • Gaetano Rocco

      Affiliations

    • Department of Thoracic Surgery and Oncology, National Cancer Institute, Naples, Italy
    • ,
  • Giuseppe Pirozzi

      Affiliations

    • Department of Experimental Oncology, National Cancer Institute, Via Mariano Semmola, 80131 Naples, Italy
    • Corresponding Author InformationCorresponding author. Tel.: +39 0815903534; fax: +39 0815903814.

Received 3 March 2010 ,Revised 25 June 2010 ,Accepted 18 July 2010.

References 

  1. Pelosi G, Sonzogni A, De Pas T, Galetta D, Veronesi G, Spaggiari L, et al. Pulmonary sarcomatoid carcinomas: a practical overview. Int J Surg Pathol. 2009 January 14;
  2. Koss MN, Hochholzer L, O’Leary T. Pulmonary blastomas. Cancer. 1991;67:2368–2381
  3. Yousem SA, Wick MR, Randhawa P, Manivel JC. Pulmonary blastoma. An immunohistochemical analysis with comparison with fetal lung in its pseudoglandular stage. Am J Clin Pathol. 1990;93:167–175
  4. Berho M, Moran CA, Suster S. Malignant mixed epithelial/mesenchymal neoplasms of the lung. Semin Diagn Pathol. 1995;12:123–139
  5. Nakatani Y, Miyagi Y, Takemura T, Oka T, Yokoi T, Takagi M, et al. Aberrant nuclear/cytoplasmic localization and gene mutation of beta-catenin in classic pulmonary blastoma: betacatenin immunostaining is useful for distinguishing between classic pulmonary blastoma and a blastomatoid variant of carcinosarcoma. Am J Surg Pathol. 2004;28:921–927
  6. Thompson LD, Chang B, Barsky SH. Monoclonal origins of malignant mixed tumors (carcinosarcomas). Am J Surg Pathol. 1996;20:277–285
  7. Nishida K, Kobayashi Y, Ishikawa Y, Satoh Y, Okumura S, Nishimura H, et al. Sarcomatoid adenocarcinoma of the lung: clinicopathological, immunohistochemical and molecular analyses. Anticancer Res. 2002;22:3477–3483
  8. Dacic S, Finkelstein SD, Sasatomi E, Swalsky PA, Yousem SA. Molecular pathogenesis of pulmonary carcinosarcoma as determined by microdissection-based allelotyping. Am J Surg Pathol. 2002;26:510–516
  9. Holst VA, Finkelstein S, Colby TV, Myers JL, Yousem SA. p53 an K-ras mutational genotyping in pulmonary carcinosarcoma, spindle cell carcinoma, and pulmonary blastoma: implications for histogenesis. Am J Surg Pathol. 1997;21:801–811
  10. Bodner SM, Koss MN. Mutations in the p53 gene in pulmonary blastomas: immunohistochemical and molecular studies. Hum Pathol. 1996;27:1117–1123
  11. Pelosi G, Scarpa A, Manzotti M, Veronesi G, Spaggiari L, Fraggetta F, et al. K-Ras gene mutational analysis supports a monoclonal origin of biphasic pulmonary sarcomatoid carcinomas of the lung. Mod Pathol. 2004;17:538–546
  12. Przygodzki RM, Koss MN, Moran CA, Langer JC, Swalsky PA, Fishback N, et al. Pleomorphic (giant and spindle cell) carcinoma is genetically distinct from adenocarcinoma and squamous cell carcinoma by K-Ras-2 and p53 analysis. Am J Clin Pathol. 1996;106:487–492
  13. Przygodzki RM, Koss MN, O’Leary TJ. Pleomorphic (giant and/or spindle cell) carcinoma of lung shows a high percentage of variant CYP1A12. Mol Diagn. 2001;6:109–115
  14. Sekine S, Shibata T, Matsuno Y, Maeshima A, Ishii G, Sakamoto M, et al. Beta-catenin mutations in pulmonary blastomas: association with morule formation. J Pathol. 2003;200:214–221
  15. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer and cancer stem cells. Nature. 2001;414:105–111
  16. Al-Hajj M, Clarke MF. Self-renewal and solid tumor stem cells. Oncogene. 2004;23:7274–7282
  17. Jordan CT, Guzman ML, Noble M. Cancer stem cells. N Engl J Med. 2006;355:1253–1261
  18. Graziano A, d’Aquino R, Tirino V, Desiderio V, Rossi A, Pirozzi G. The stem cell hypothesis in head and neck cancer. J Cell Biochem. 2008;103:408–412
  19. Tirino V, Camerlingo R, Franco R, Malanga D, La Rocca A, Viglietto G, et al. The role of CD133 in the identification and characterisation of tumour-initiating cells in non-small-cell lung cancer. Eur J Cardiothorac Surg. 2009;36(September (3)):446–453
  20. Yang P, Morizumi H, Sano T, Hirose T, Hasegawa T, Seki K, et al. Pulmonary blastoma: an ultrastructural and immunohistochemical study with special reference to nuclear filament aggregation. Ultrastruct Pathol. 1995;19(November–December (6)):501–509
  21. Lyda MH, Weiss LM. Immunoreactivity for epithelial and neuroendocrine antibodies are useful in the differential diagnosis of lung carcinomas. Hum Pathol. 2000;31:980–987
  22. Nakamura N, Miyagi E, Murata S, Kawaoi A, Katoh R. Expression of thyroid transcription factor-1 in normal and neoplastic lung tissues. Mod Pathol. 2002;15:1058–1067
  23. Goodell MA, Brose K, Paradis G, Conner AS, Mulligan RC. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med. 1996;183:1797–1806
  24. Koss M, Travis W, Moran C. Pulmonary sarcomas, blastomas, carcinosarcomas and teratomas. Spencer's histopathology of the lung. 5th ed.. New York, NY: McGraw Hill; 1996;p. 1092–100
  25. Rajeshwara Krishna Prasad Adluri , Srikanth Reddy Boddu , Antonio Martin-Ucar , John Peter Duffy , Frederick David Beggs , William Ellis Morgan . Pulmonary blastoma—a rare tumor with variable presentation. Eur J Cardiothorac Surg. 2006;29:236–239
  26. Senac MO, Wood BP, Isaacs H, Weller M. Pulmonary blastoma: a rare childhood malignancy. Radiology. 1991;179:743–746
  27. Liman ST, Altinok T, Topcu S, Tastepe AI, Uzar A, Demircan S, et al. Survival of biphasic pulmonary blastoma. Respir Med. 2006;100(July (7)):1174–1179
  28. Larue L, Bellacosa A. Epithelial–mesenchymal transition in development and cancer: role of phosphatidylinositol 3′ kinase/AKT pathways. Oncogene. 2005 November 14;24(50):7443–7454
  29. Derek C, Radisky . Epithelial–mesenchymal transition. J Cell Sci. 2005;118:4325–4326
  30. Singh SK, Hawkins C, Clarke ID, Bayani J, Hide T, Henkelman RM, et al. Identification of human brain tumour initiating cells. Nature. 2004 November 18;432(7015):396–401
  31. Uchida N, Buck DW, He D, Reitsma MJ, Masek M, Phan TV, et al. Direct isolation of human central nervous system stem cells. Proc Natl Acad Sci USA. 2000;97:14720–14725
  32. Lardon J, Corbeil D, Huttner WB, Ling Z, Bouwens L, et al. Stem cell marker prominin-1/AC133 is expressed in duct cells of the adult human pancreas. Pancreas. 2008;36:e1–e6
  33. Yin AH, Miraglia S, Zanjani ED, Almeida-Porada G, Ogawa M, Leary AG, et al. AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood. 1997;90:5002–5012

☆ Grant support: Current Research 2008 of the Italian Department of Health to G. Pirozzi and G. Rocco.

PII: S0169-5002(10)00369-7

doi: 10.1016/j.lungcan.2010.07.009

Lung Cancer
Volume 72, Issue 1 , Pages 23-31 , April 2011

Article Tools

* Image Usage & Resolution